Chemistree Technology Inc banner
C

Chemistree Technology Inc
OTC:CHMJD

Watchlist Manager
Chemistree Technology Inc
OTC:CHMJD
Watchlist
Price: 0.0051 USD Market Closed
Market Cap: $379.6k

Relative Value

There is not enough data to reliably calculate the relative value of CHMJD.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHMJD Relative Value
Base Case
Not Available
C
Worst Case
Base Case
Best Case

Multiples Across Competitors

CHMJD Competitors Multiples
Chemistree Technology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Chemistree Technology Inc
OTC:CHMJD
3.7m USD 0 -3.7 -5.3 -5.6
US
Eli Lilly and Co
NYSE:LLY
867.4B USD 13.3 42 28.4 30.3
US
Johnson & Johnson
NYSE:JNJ
571.4B USD 6.1 21.3 14.8 18.2
CH
Roche Holding AG
SIX:ROG
257.8B CHF 4.2 20 11.8 13.3
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP 5 28.9 16 22.6
CH
Novartis AG
SIX:NOVN
228.9B CHF 5.2 21.1 13.1 16.8
US
Merck & Co Inc
NYSE:MRK
283.3B USD 4.4 15.5 9.6 11.7
IE
Endo International PLC
LSE:0Y5F
240.1B USD 103.6 -82.1 380.1 953.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.5 10.5 7.8 9.1
US
Pfizer Inc
NYSE:PFE
155.3B USD 2.5 20 7.7 10.2
US
Bristol-Myers Squibb Co
NYSE:BMY
119.5B USD 2.5 17 7.1 8.8
P/E Multiple
Earnings Growth PEG
CA
C
Chemistree Technology Inc
OTC:CHMJD
Average P/E: 21.8
Negative Multiple: -3.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.3
7%
3
CH
Roche Holding AG
SIX:ROG
20
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
28.9
26%
1.1
CH
Novartis AG
SIX:NOVN
21.1
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.5
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -82.1 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.5
1%
10.5
US
Pfizer Inc
NYSE:PFE
20
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
C
Chemistree Technology Inc
OTC:CHMJD
Average EV/EBITDA: 49.6
Negative Multiple: -5.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.4
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.8
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
UK
AstraZeneca PLC
LSE:AZN
16
13%
1.2
CH
Novartis AG
SIX:NOVN
13.1
5%
2.6
US
Merck & Co Inc
NYSE:MRK
9.6
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
380.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.8
1%
7.8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
C
Chemistree Technology Inc
OTC:CHMJD
Average EV/EBIT: 109.4
Negative Multiple: -5.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.3
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.2
7%
2.6
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
22.6
21%
1.1
CH
Novartis AG
SIX:NOVN
16.8
9%
1.9
US
Merck & Co Inc
NYSE:MRK
11.7
6%
2
IE
E
Endo International PLC
LSE:0Y5F
953.2
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
3%
3
US
Pfizer Inc
NYSE:PFE
10.2
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett